Article List

WPRIM Management System> DCMS> Journal of Experimental Hematology> 2016> 24> 2

Volume: 24 Issue: 2

1. Research Advances of IDH2 Gene Mutation in Acute Myeloid Leukemia.	Page:632—636
2. γ-Globin Inductive Therapy of β-thalassemia and Its Relationship with MicroRNA.	Page:627—631
3. Progress of Research on 6-Thioguanine versus 6-Mercaptopurine in childhood ALL.	Page:622—626
4. Application of Cytotoxic T-Lymphocytes for the Treatment of Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation.	Page:616—621
5. Improvement and Evaluation on Bisulfite Modification of DNA for DNA Methylation Detection.	Page:611—615
6. Effects of Two Placement Ways for Storage of Blood Bag on Biochemical Indexes of Leukodepleted Red Blood Cells.	Page:607—610
7. Polymorphism of Platelet Specific Antigens (HPA-1-5, 15) in Han Donors in the North Area of Henan Province.	Page:602—606
8. Effect of MicroRNA-146a on Differentiation Potential of Human Bone Marrow Mesenchymal Stem Cells.	Page:596—601
9. Regulation of SIRT1 by SREBP-1 in Adipogenic Differentiation of Mesenchymal Stem Cells.	Page:590—595
10. Modulatory Effect of Mouse Compact Bone-derived Suspending MSC on T Cells and It's Related Mechanisms.	Page:584—589
11. Clinical Therapy and Prognostic Analysis of 61 Patients with Secondary Hemophagocytic Syndrome.	Page:580—583
12. Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness.	Page:573—579
13. Influence of HSCT Preconditioning on ADAMTS-13 Activity and vWF level and Its Clinical Significance.	Page:568—572
14. Two Kinds of HLA-mismatched Allogeneic Hematopoictic Stem Cell Transplantation for Treatment of Hematologic Malignancies.	Page:562—567
15. Clinical Summarization of Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: A Report of 100 Cases.	Page:556—561
16. Analysis of Risk Factors for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.	Page:551—555
17. Clinical Significance of Hepcidin in the Diagnosis of Infant Iron Deficiency Anemia.	Page:546—550
18. Genotype of Patients with α and β Thalassemia in Northern Area of Fujian Province in China.	Page:540—545
19. Analysis of Cut-off Value in Screening of Thalassemia by Capillary Hemoglobin Electrophoresis for Pregnant Women from Shenzhen Region of China.	Page:536—539
20. Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia.	Page:531—535
21. Role of PDGF/PDGFR Pathway in Essential Thrombocythemia and Its Action Mechanism.	Page:526—530
22. Factor Xa Promotes Differentiation of Meg-01 Cell Line.	Page:519—525
23. Diagnostic Value of Combined Examination Using 5 Technigues for Myelodysplastic Syndrome.	Page:515—518
24. Clinical Efficacy Comparison of Ultralow Dose of Decitabine and Cyclosporine on Low-risk and Intermediate-risk Type 1 of Myelodysplastic Syndrome.	Page:510—514
25. Clinic Outcome of Allogeneic Stem Cell Transplantation in 45 Patients with MDS.	Page:502—509
26. Curative Efficacy of Lenalidomide plus Low Dose Dexamethasone for Multiple Myeloma.	Page:498—501
27. As2O3 Up-regulates the Autophagy of RPMI 8226 Cells Induced by Beclin-1.	Page:492—497
28. Clinical Features of 46 Multiple Myeloma Patients with Different Renal Pathology.	Page:487—491
29. Effect and Safety of CIK Cell Infusion on Peripheral Blood Immune Cell Level in the Elderly Patients with Multiple Myeloma.	Page:482—486
30. Relationship between M-Protein of Multiple Myeloma and False Positive Syphilis Serological Results.	Page:478—481
31. Clinical Characteristics and Therapeutic Efficacy of Multiple Myeloma Combined with Renal Amyloidosis.	Page:474—477
32. Effects of Bone Marrow Mesenchymal Stem Cells on the Biological Characteristics of Migrating and Homing in Multiple Myeloma Cells.	Page:469—473
33. Clinical Analysis of Multiple Myeloma Patients Aged over 80 Years.	Page:463—468
34. Prognostic and Therapeutic Significance of Molecular Subtyping on Aged Patient with Advanced Diffuse Large B Cell Lymphoma---A Case Report.	Page:457—462
35. Primary Breast Diffuse Large B Cell Lymphoma: Summarization of 12 Cases.	Page:452—456
36. Clinical Efficacy Comparison of Different Second Line Salvage Chemotherapy Regimens for the Treatment of Elderly Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma.	Page:448—451
37. Clinical Therapeutic Efficacy of Rituximab Combined with Methotrexate on Primary Central Nervous System Lymphoma.	Page:444—447
38. Analysis of Clinical Characteristics and Prognosis of 46 Elderly Patients with Peripheral T Cell Lymphoma (PTCL).	Page:438—443
39. Therapeutic Efficacy Analysis of Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation for 14 Adult Patients with T Lymphoblastic Lymphoma.	Page:433—437
40. Value of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio for Prognostic Evaluation of Diffuse Large B-cell Lymphoma.	Page:427—432
41. Knockout of Micro-RNA-21 Gene in DLBCL OCI-Ly3 cells by TALEN Technique.	Page:422—426
42. Analysis of Factors Influencing Peripheral Blood Stem Cell Collection of 151 Lymphoma Cases.	Page:416—421
43. Inhibitory Effect of High Concentration Insulin on K562 Cell Proliferation and Its Mechanism.	Page:411—415
44. Comparison of the Effectiveness and Safety of Combined Chemotherapy with PEG-Asp for Treatment of ALL and T-NHL Patients.	Page:405—410
45. Effectiveness of CLAT Protocol for Treating Patients with Refractory Acute Myeloid Leukemia.	Page:399—404
46. Clinical Efficacy of Sorafenib Combined with Low Dose Cytarabine for Treating Patients with FLT3+ Relapsed and Refractory Acute Myeloid Leukemia.	Page:394—398
47. Effect of Magnolol on Proliferation and Apoptosis of HL-60 Cells and Its Molecular Mechanism.	Page:388—393
48. Application of High-throughput Sequencing in Acute Myeloid Leukemia Patients with Positive FLT3-ITD.	Page:381—387
49. Signal Patterns of Dual Color Dual Fusion Fluorescence in Situ Hybridization for Detection of Genetic Abnormality in Adult Patients with ALL and Their Clinical Application.	Page:375—380
50. Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI.	Page:369—374
51. Antiapoptotic Effect of the Leukemia Associated Gene MLAA-34 in HeLa Cells.	Page:363—368
52. Expression and Significance of NLRP3, ASC and AIM2 in Patients with Acute Leukemia.	Page:358—362
53. Application of Combined Detection of Fusion Gene and BIOMED-2 Standardized Ig Gene Rearrangement System in Childhood B-cell Acute Lymphoblastic Leukemia.	Page:352—357
54. MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM.	Page:347—351
55. Effect of Inhibiting and Activating Wnt Signalling Pathway on NSC67657-inducing Monocytic Differentiation of HL-60 Cells.	Page:341—346
56. Expression of miR-34a in Bone Marrow of Adult Acute Lymphoblastic Leukemia and Its Significance in Cell Drug Resistance.	Page:336—340
57. Expression of CD25 in Acute Myeloid Leukemia Is An Adverse Prognostic Factor Independent of the Chromosome Karyotype.	Page:332—335
58. Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance.	Page:326—331
59. Immunophenotypic Analysis of Acute Promyelocytic Leukemia.	Page:321—325
60. Expression and Significance of Pim-3 Gene in Acute Myeloid Leukemia.	Page:316—320
61. Expression and Clinical Significance of CC-chemokine Receptor 7 in Adult Acute Leukemia.	Page:311—315